Chief Business Officer
Pharmaceutical Sciences
Sotio
Czech Republic
Jens Hennecke is an Chief Business Officer Working at Sotio is a biotechnology company developing a new Active Cellular Immunotherapy (“ACIâ€) based on activated dendritic cells for the treatment of cancer and autoimmune diseases. SOTIO continues to develop new therapies to address unmet medical needs using its immunotherapy platform and proprietary cell-based technologies.
Pharmaceutical Industry, GMP, Quality Control, Pharmaceutical Manufacturing,Clinical Trails ,Clinical Research